Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes.
Int J Pharm
; 569: 118585, 2019 Oct 05.
Article
en En
| MEDLINE
| ID: mdl-31376467
In this work, we implemented a supramolecular approach in order to combine photodynamic therapy (PDT) with gene therapy. We made use of a simple cationic guanidylated porphyrin (H2PG) with the hypothesis that porphyrin aggregates should be capable of complexing siRNA through multivalent interactions and thus contribute to its intracellular delivery, while remaining active photosensitizers for PDT. The PDT effect of H2PG was shown by incubating human breast cancer cells (MDA-MB-231) with H2PG followed by light-irradiation at 405â¯nm. On the other hand, while siRNA do not enter cells alone, we showed, by fluorescence confocal microscopy and flow cytometry, that H2PG promotes the internalization of Atto-488 siRNA. Finally, studying the combined PDT and delivery of siRNA directed against inhibitory apoptotic protein (IAP) family, we found an additive effect of the two therapies, thereby demonstrating that H2PG is capable of acting both as a photosensitizer and supramolecular siRNA vector.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fotoquimioterapia
/
Porfirinas
/
Fármacos Fotosensibilizantes
/
Silenciador del Gen
/
ARN Interferente Pequeño
Límite:
Humans
Idioma:
En
Revista:
Int J Pharm
Año:
2019
Tipo del documento:
Article
País de afiliación:
Francia
Pais de publicación:
Países Bajos